No drug is without potential side effects, and there are five major ones that people taking Ozempic, Wegovy or Mounjaro are ...

American teens are increasingly turning to the weight-loss drug Wegovy, as more families and their doctors gain confidence in ...

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

By the end of the study, people on the maximum dose of Zepbound lost an average of about 50 ... lb (13.7 percent of their body weight) with Wegovy. More weight loss wasn’t the only advantage ...

Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...

Share on Pinterest Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial ... lost more weight after 72 weeks (average loss of 20.2% compared to 13.7% for ...

Novo Nordisk told Reuters in a statement that a similar dose of Wegovy led to greater weight loss in a 2021 trial ... Zepbound shed about 50.3 pounds, on average, while those who used Wegovy ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50 per cent more weight than those using rival Novo Nordisk's Wegovy.

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

The first head-to-head trial of two blockbuster weight-loss drugs has shown Mounjaro is more effective than rival Wegovy.